Market Sentiment Stabilizes as Sanctions Prove Largely Symbolic; Tech Benchmarks Surge on Potential Dovish Fed Signals

Stock News
1 hour ago

Market dynamics took a surprising turn today as the harsh "devastating" sanctions threatened by the U.S. yesterday turned out to be more bark than bite. A-shares closed higher while Hong Kong stocks dipped a marginal 0.02%, reflecting a market that quickly shrugged off the geopolitical noise.

The specifics show Washington expanding economic sanctions against Iran to cover aviation, digital assets, gold, shipping, and technology sectors, while suspending licenses related to educational activities, personal remittances, sports, and academic exchanges. Around 60 Iranian-linked entities and individuals were added to the sanctions list, spanning nuclear and missile technology, cyber operations, and oil trade. Treasury Secretary Bessent issued a global warning urging nations to sever financial ties with Tehran or risk exclusion from the dollar system, but these measures appear largely symbolic. The critical question remains whether Iranian oil trade gets truly blocked, with major buyers clearly identifiable and secondary sanctions likely only intimidating smaller nations. Diplomatic efforts continue in parallel, with Pakistan's Army Chief and Interior Minister concluding a one-day visit to Iran focused on preventing escalation and reopening the Strait of Hormuz, with Tehran showing signs of flexibility on the strait issue. Consequently, gold and shipping sectors are adjusting today.

On the U.S. debt front, Bessent announced a $1 trillion treasury purchase program, dwarfing the previous $4 billion and signaling a serious attempt at market stabilization despite being seen as a stopgap measure. The unexpected tech rebound today stems from afternoon reports suggesting Waller might provide crucial updates on the Fed's inflation approach at the Jackson Hole symposium, potentially offering much-needed market certainty. Given Trump's declining approval ratings and persistently high long-term treasury yields, the Fed may be compelled to signal dovish intentions to ease political pressure.

Adding to the tech optimism, Elon Musk announced a deep partnership between SpaceX and NVIDIA to develop the Vera Rubin NVL72 computing system for space environments, with first AI satellites launching in Q4 2027 and full orbital deployment by 2028, potentially realizing the first space-based data center. Two benchmark tech names posted stellar results: YOFC (06869) surged over 15% after first-half profits jumped 888.88% with a proposed dividend of RMB 10.6 per 10 shares, while KB Laminates (01888) climbed nearly 14% following a 55% revenue increase to HK$14.9 billion and 209% profit growth to HK$2.887 billion. Kingboard Holdings (00148) also rose nearly 12% with revenue up 35% to HK$29.131 billion, and Chairman Cheung Kwok-wing expressed confidence both companies will exceed HK$10 billion in annual profits. Sustained strength from these leaders could lift the entire tech sector.

The CXO sector received another earnings catalyst as Asymchem (06821) reported first-half revenue of RMB 3.61 billion, up 13.1%, with 2026 full-year growth projected at 19%-22%. The order book remains the key metric, with total orders reaching $1.673 billion, up 53.77% year-on-year, and new orders surging 54.59% in early 2026, particularly strong in chemical and biological macromolecules. Shares jumped over 16%. WuXi XDC (02268) also impressed with revenue rising 37% to RMB 3.701 billion, net profit up 37.4% to RMB 1.027 billion, and total outstanding orders including potential milestones growing 62.2% to approximately $2.2 billion, driving shares up nearly 15%. WuXi Bio (02269) and Genscript Bio (01548) both advanced over 7%. Industry tailwinds continue with the National Medical Products Administration supporting generic drug development and international cooperation, while China's innovative drug out-licensing deals reached approximately $110 billion in H1 2026, hitting 80% of 2025's full-year total, with July alone seeing 12 cross-border licensing deals worth $9.253 billion, reflecting growing global recognition of domestic innovation.

Everest Medicines (01952) achieved adjusted profit breakeven with core product Nefecon sales reaching RMB 889 million, up 94% in pure sales terms, with expanding hospital coverage. The company's end-to-end mRNA platform and AI-driven personalized tumor vaccine EVM16 and off-the-shelf EVM14 pipeline drove shares up over 18%. Remegen (09995) and Innocare (09969) both turned profitable and delivered strong BD performance, rising over 8% each. The draft Road Traffic Safety Law amendment introduces a dedicated chapter on autonomous vehicles, establishing legal foundations for liability, traffic rules, and consequences, which will push automakers to improve algorithm safety and data traceability mechanisms. Zhejiang Shibao (01057) and Nexteer (01316) gained over 4%. East Buy (01797) continued its rally, rising nearly 10% today as investors bet on rapid growth in its self-operated business, with the unique model of departed top anchors actually boosting overall traffic and brand awareness.

This year's El Ni帽o event is projected to be the strongest in modern meteorological records, potentially intensifying droughts and extreme rainfall globally while disrupting agricultural production. U.S. heartland farmers face their worst crisis in 40 years, with diesel and fertilizer prices pushed higher by the Iran conflict plus trade war factors threatening producer viability. Farm Bureau research indicates farmers growing nine major crops including corn would lose $31 billion without government assistance. Hong Kong-listed agricultural plays with relatively rigid demand logic include October Agriculture (09676), Sinofert (00297), Muyuan Foods (02714), DeKang Agriculture (02419), Youran Dairy (09858), and China Modern Dairy (01117).

Marketingforce (02556) posted outstanding interim results with total revenue of RMB 1.96 billion, up 111.2%, AI application revenue of RMB 1.13 billion, up 123.7%, and net profit of RMB 200 million, surging 466.1% with adjusted net profit up 150.9% to RMB 213 million. The company is rapidly deploying AI agents for foreign trade, with 2025 overseas revenue reaching RMB 75.934 million, up 134.4%, and 2026 H1 overseas revenue growing 89% with 982 overseas paying clients. AI business now accounts for over half of revenue, with Q1 AI revenue up 110.5% versus 0.9% for traditional marketing. The core AI-Agentforce 3.0 platform with proprietary GEO large model integrates multiple frameworks including Baidu and Alibaba models for optimal cost and control. With over 1,000 reusable knowledge graphs serving 210,000+ enterprises and partners including Baidu, Alibaba Cloud, Moxin (domestic GPU), and OceanBase for sovereign AI infrastructure, the company is accelerating global expansion into Southeast Asia, the Middle East, and Europe. Its token factory model charges based on output value, achieving over 60% computing self-sufficiency, making it a rare domestic AI application leader with self-owned computing power. KA client numbers have doubled with increasing AI agent penetration and pay-for-performance pricing improving margins. With batch AI agent orders across consumer, automotive, and financial sectors, long-term framework agreements, and high renewal rates, the company's AI revenue has doubled with the token economy model and overseas expansion providing significant long-term growth opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10